BioCentury
ARTICLE | Finance

Ebb & Flow

November 16, 2009 8:00 AM UTC

Although the terms of the acquisition of BioTrove Inc. by Life Technologies Corp. (NASDAQ:LIFE) haven't been undisclosed, the transaction could result in a more than 10X return over the next 12 months, according to investor Otello Stampacchia of Omega Funds.

"There are going to be some contingencies: the initial upfront payment and a bunch of sales milestones for a product that's already on the market," he said. "With the short term milestones, we get to a pretty high multiple. We get to a double-digit return if we get lucky; I don't think we'll be too far off that."...